The US Food and Drug Administration will now require Covid-19 vaccines from Pfizer/BioNTech and Moderna to use expanded ...

The FDA will now require clinical trials to approve boosters for healthy Americans under 65, making it unlikely the shots ...

The agency said it would approve new versions of the vaccine only for adults 65 years of age and older as well as for people with one or more risk factors for severe COVID-19 outcomes. These risk ...

Older adults can continue getting covid boosters, but not everyone who wants them can. You’re reading The Checkup With Dr.

The FDA is moving to restrict COVID vaccination to adults 65 and older and other particularly vulnerable people. Learn what’s ...

The FDA will continue recommending annual COVID-19 vaccines for older adults and high-risk groups, but says more clinical ...

The shift was a marked departure from previous FDA guidance, which recommended an annual COVID vaccine for everyone 6 months ...

Previously, updated COVID vaccines had been recommended annually by the CDC for everyone over the age of 6 months. The CDC has historically set vaccine recommendations, while the FDA determines which ...

The U.S. Food and Drug Administration (FDA) is changing the game on COVID-19 vaccines. Instead of approving yearly boosters ...

The US Food and Drug Administration is changing the way it approves Covid-19 vaccines for Americans, a move that may limit future shots to older Americans and people at higher risk of serious Covid-19 ...

Applied Clinical Trials is the thought leader in pharmaceutical drug development operations and clinical trial design, ...